Clinical Takeaway
A randomized controlled trial tested the Minder mobile app, co-developed with university students, to address mental health and substance use challenges during the college transition period. Digital tools like this are being studied because they can reach large numbers of students in a scalable and accessible way. Results from this trial provide direct clinical evidence on whether app-based interventions can meaningfully improve mental health and substance use outcomes in this high-risk population.
#5 Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.
Citation: Vereschagin Melissa et al.. Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.. Journal of medical Internet research. 2024. PMID: 38536225.
Design: 5 Journal: 0 N: 3 Recency: 1 Pop: 2 Human: 1 Risk: 0
This RCT provides empirical evidence for the clinical efficacy of a student-centered digital intervention during a critical developmental period when mental health and substance use disorders frequently emerge. The scalability of mobile apps positions evidence-based digital interventions as a practical solution to address the significant treatment gap in university populations who have limited access to traditional mental health services. Demonstrating effectiveness in this age group could inform institutional adoption strategies and support the integration of validated digital tools into campus mental health infrastructure.
Abstract: BACKGROUND: University attendance represents a transition period for students that often coincides with the emergence of mental health and substance use challenges. Digital interventions have been identified as a promising means of supporting students due to their scalability, adaptability, and acceptability. Minder is a mental health and substance use mobile app that was codeveloped with university students. OBJECTIVE: This study aims to examine the effectiveness of the Minder mobile app in improving mental health and substance use outcomes in a general population of university students. METHODS: A 2-arm, parallel-assignment, single-blinded, 30-day randomized controlled trial was used to evaluate Minder using intention-to-treat analysis. In total, 1489 participants were recruited and randomly assigned to the intervention (n=743, 49.9%) or waitlist control (n=746, 50.1%) condition. The Minder app delivers evidence-based content through an automated chatbot and connects participants with services and university social groups. Participants are also assigned a trained peer coach to support them. The primary outcomes were measured through in-app self-assessments and included changes in general anxiety symptomology, depressive symptomology, and alcohol consumption risk measured using the 7-item General Anxiety Disorder scale, 9-item Patient Health Questionnaire, and US Alcohol Use Disorders Identification Test-Consumption Scale, respectively, from baseline to 30-day follow-up. Secondary outcomes included measures related to changes in the frequency of substance use (cannabis, alcohol, opioids, and nonmedical stimulants) and mental well-being. Generalized linear mixed-effects models were used to examine each outcome. RESULTS: In total, 79.3% (589/743) of participants in the intervention group and 83% (619/746) of participants in the control group completed the follow-up survey. The intervention group had significantly greater average reductions in anxiety symptoms measure
🧠 The Minder app study demonstrates a thoughtful approach to addressing mental health and substance use in a vulnerable population, yet clinicians should note several important limitations when considering this intervention for their patients. Digital mental health tools show promise for scalability and engagement, particularly among university-aged individuals who may underutilize traditional mental health services, but the effectiveness of any app-based intervention depends heavily on user adherence, baseline motivation, and the presence of adequate clinical support infrastructure alongside the technology itself. The study’s reliance on self-reported outcomes and the inevitable selection bias toward digitally-engaged students limit generalizability to the broader patient population you may encounter in clinical practice. Additionally, mobile apps function best as adjunctive tools rather than replacements for evidence-based psychotherapy or medication management, particularly for students presenting with moderate-to-severe symptoms requiring real-time clinical assessment. In practice, consider recommending Minder as a supportive resource for engaged students with mild-to-moderate concerns while maintaining your own clinical oversight, particularly when substance use